1 Study Coverage 1.1 Respiratory Diseases Diagnostic Testing Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Introduction 1.2 Global Respiratory Diseases Diagnostic Testing Outlook 2017 VS 2022 VS 2028 1.2.1 Global Respiratory Diseases Diagnostic Testing Market Size for the Year 2017-2028 1.2.2 Global Respiratory Diseases Diagnostic Testing Market Size for the Year 2017-2028 1.3 Respiratory Diseases Diagnostic Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Respiratory Diseases Diagnostic Testing in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Respiratory Diseases Diagnostic Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Respiratory Diseases Diagnostic Testing Market Dynamics 1.4.1 Respiratory Diseases Diagnostic Testing Industry Trends 1.4.2 Respiratory Diseases Diagnostic Testing Market Drivers 1.4.3 Respiratory Diseases Diagnostic Testing Market Challenges 1.4.4 Respiratory Diseases Diagnostic Testing Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Respiratory Diseases Diagnostic Testing by Type 2.1 Respiratory Diseases Diagnostic Testing Market Segment by Type 2.1.1 Imaging Test 2.1.2 Respiratory Measurement 2.1.3 Blood Gas Test 2.1.4 Other 2.2 Global Respiratory Diseases Diagnostic Testing Market Size by Type (2017, 2022 & 2028) 2.3 Global Respiratory Diseases Diagnostic Testing Market Size by Type (2017-2028) 2.4 United States Respiratory Diseases Diagnostic Testing Market Size by Type (2017, 2022 & 2028) 2.5 United States Respiratory Diseases Diagnostic Testing Market Size by Type (2017-2028) 3 Respiratory Diseases Diagnostic Testing by Application 3.1 Respiratory Diseases Diagnostic Testing Market Segment by Application 3.1.1 Hospitals 3.1.2 Physician Clinics 3.1.3 Clinical Laboratories 3.1.4 Others 3.2 Global Respiratory Diseases Diagnostic Testing Market Size by Application (2017, 2022 & 2028) 3.3 Global Respiratory Diseases Diagnostic Testing Market Size by Application (2017-2028) 3.4 United States Respiratory Diseases Diagnostic Testing Market Size by Application (2017, 2022 & 2028) 3.5 United States Respiratory Diseases Diagnostic Testing Market Size by Application (2017-2028) 4 Global Respiratory Diseases Diagnostic Testing Competitor Landscape by Company 4.1 Global Respiratory Diseases Diagnostic Testing Market Size by Company 4.1.1 Top Global Respiratory Diseases Diagnostic Testing Companies Ranked by Revenue (2021) 4.1.2 Global Respiratory Diseases Diagnostic Testing Revenue by Player (2017-2022) 4.2 Global Respiratory Diseases Diagnostic Testing Concentration Ratio (CR) 4.2.1 Respiratory Diseases Diagnostic Testing Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Respiratory Diseases Diagnostic Testing in 2021 4.2.3 Global Respiratory Diseases Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Respiratory Diseases Diagnostic Testing Headquarters, Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Type 4.3.1 Global Respiratory Diseases Diagnostic Testing Headquarters and Area Served 4.3.2 Global Respiratory Diseases Diagnostic Testing Companies Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Respiratory Diseases Diagnostic Testing Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Respiratory Diseases Diagnostic Testing Market Size by Company 4.5.1 Top Respiratory Diseases Diagnostic Testing Players in United States, Ranked by Revenue (2021) 4.5.2 United States Respiratory Diseases Diagnostic Testing Revenue by Players (2020, 2021 & 2022) 5 Global Respiratory Diseases Diagnostic Testing Market Size by Region 5.1 Global Respiratory Diseases Diagnostic Testing Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Respiratory Diseases Diagnostic Testing Market Size by Region (2017-2028) 5.2.1 Global Respiratory Diseases Diagnostic Testing Market Size by Region: 2017-2022 5.2.2 Global Respiratory Diseases Diagnostic Testing Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Respiratory Diseases Diagnostic Testing Market Size YoY Growth 2017-2028 6.1.2 North America Respiratory Diseases Diagnostic Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Respiratory Diseases Diagnostic Testing Market Size YoY Growth 2017-2028 6.3.2 Europe Respiratory Diseases Diagnostic Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Respiratory Diseases Diagnostic Testing Market Size YoY Growth 2017-2028 6.4.2 Latin America Respiratory Diseases Diagnostic Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Respiratory Diseases Diagnostic Testing Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Respiratory Diseases Diagnostic Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Philips Healthcare 7.1.1 Philips Healthcare Company Details 7.1.2 Philips Healthcare Business Overview 7.1.3 Philips Healthcare Respiratory Diseases Diagnostic Testing Introduction 7.1.4 Philips Healthcare Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.1.5 Philips Healthcare Recent Development 7.2 BD 7.2.1 BD Company Details 7.2.2 BD Business Overview 7.2.3 BD Respiratory Diseases Diagnostic Testing Introduction 7.2.4 BD Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.2.5 BD Recent Development 7.3 Abbott 7.3.1 Abbott Company Details 7.3.2 Abbott Business Overview 7.3.3 Abbott Respiratory Diseases Diagnostic Testing Introduction 7.3.4 Abbott Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.3.5 Abbott Recent Development 7.4 Thermo Fisher Scientific 7.4.1 Thermo Fisher Scientific Company Details 7.4.2 Thermo Fisher Scientific Business Overview 7.4.3 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Introduction 7.4.4 Thermo Fisher Scientific Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.4.5 Thermo Fisher Scientific Recent Development 7.5 Roche 7.5.1 Roche Company Details 7.5.2 Roche Business Overview 7.5.3 Roche Respiratory Diseases Diagnostic Testing Introduction 7.5.4 Roche Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.5.5 Roche Recent Development 7.6 ResMed 7.6.1 ResMed Company Details 7.6.2 ResMed Business Overview 7.6.3 ResMed Respiratory Diseases Diagnostic Testing Introduction 7.6.4 ResMed Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.6.5 ResMed Recent Development 7.7 Fischer & Paykel 7.7.1 Fischer & Paykel Company Details 7.7.2 Fischer & Paykel Business Overview 7.7.3 Fischer & Paykel Respiratory Diseases Diagnostic Testing Introduction 7.7.4 Fischer & Paykel Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.7.5 Fischer & Paykel Recent Development 7.8 Medtronic 7.8.1 Medtronic Company Details 7.8.2 Medtronic Business Overview 7.8.3 Medtronic Respiratory Diseases Diagnostic Testing Introduction 7.8.4 Medtronic Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.8.5 Medtronic Recent Development 7.9 MGC Diagnostics 7.9.1 MGC Diagnostics Company Details 7.9.2 MGC Diagnostics Business Overview 7.9.3 MGC Diagnostics Respiratory Diseases Diagnostic Testing Introduction 7.9.4 MGC Diagnostics Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) 7.9.5 MGC Diagnostics Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Respiratory Diseases Diagnostic Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Respiratory Diseases Diagnostic Testing Market Trends Table 3. Respiratory Diseases Diagnostic Testing Market Drivers Table 4. Respiratory Diseases Diagnostic Testing Market Challenges Table 5. Respiratory Diseases Diagnostic Testing Market Restraints Table 6. Global Respiratory Diseases Diagnostic Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Respiratory Diseases Diagnostic Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Respiratory Diseases Diagnostic Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Respiratory Diseases Diagnostic Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Respiratory Diseases Diagnostic Testing Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Respiratory Diseases Diagnostic Testing Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Respiratory Diseases Diagnostic Testing Revenue Share by Player, 2017-2022 Table 13. Global Respiratory Diseases Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Respiratory Diseases Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2021) Table 15. Top Players of Respiratory Diseases Diagnostic Testing in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Respiratory Diseases Diagnostic Testing Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Respiratory Diseases Diagnostic Testing Players in United States Market, Ranking by Revenue (2021) Table 20. United States Respiratory Diseases Diagnostic Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Respiratory Diseases Diagnostic Testing Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Respiratory Diseases Diagnostic Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Respiratory Diseases Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Respiratory Diseases Diagnostic Testing Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Respiratory Diseases Diagnostic Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Respiratory Diseases Diagnostic Testing Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Respiratory Diseases Diagnostic Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Respiratory Diseases Diagnostic Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Respiratory Diseases Diagnostic Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Philips Healthcare Company Details Table 31. Philips Healthcare Business Overview Table 32. Philips Healthcare Respiratory Diseases Diagnostic Testing Product Table 33. Philips Healthcare Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 34. Philips Healthcare Recent Development Table 35. BD Company Details Table 36. BD Business Overview Table 37. BD Respiratory Diseases Diagnostic Testing Product Table 38. BD Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 39. BD Recent Development Table 40. Abbott Company Details Table 41. Abbott Business Overview Table 42. Abbott Respiratory Diseases Diagnostic Testing Product Table 43. Abbott Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 44. Abbott Recent Development Table 45. Thermo Fisher Scientific Company Details Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Product Table 48. Thermo Fisher Scientific Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 49. Thermo Fisher Scientific Recent Development Table 50. Roche Company Details Table 51. Roche Business Overview Table 52. Roche Respiratory Diseases Diagnostic Testing Product Table 53. Roche Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 54. Roche Recent Development Table 55. ResMed Company Details Table 56. ResMed Business Overview Table 57. ResMed Respiratory Diseases Diagnostic Testing Product Table 58. ResMed Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 59. ResMed Recent Development Table 60. Fischer & Paykel Company Details Table 61. Fischer & Paykel Business Overview Table 62. Fischer & Paykel Respiratory Diseases Diagnostic Testing Product Table 63. Fischer & Paykel Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 64. Fischer & Paykel Recent Development Table 65. Medtronic Company Details Table 66. Medtronic Business Overview Table 67. Medtronic Respiratory Diseases Diagnostic Testing Product Table 68. Medtronic Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 69. Medtronic Recent Development Table 70. MGC Diagnostics Company Details Table 71. MGC Diagnostics Business Overview Table 72. MGC Diagnostics Respiratory Diseases Diagnostic Testing Product Table 73. MGC Diagnostics Revenue in Respiratory Diseases Diagnostic Testing Business (2017-2022) & (US$ Million) Table 74. MGC Diagnostics Recent Development Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Respiratory Diseases Diagnostic Testing Product Picture Figure 2. Global Respiratory Diseases Diagnostic Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Respiratory Diseases Diagnostic Testing Market Size 2017-2028 (US$ Million) Figure 4. United States Respiratory Diseases Diagnostic Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Respiratory Diseases Diagnostic Testing Market Size 2017-2028 (US$ Million) Figure 6. United States Respiratory Diseases Diagnostic Testing Market Share in Global 2017-2028 Figure 7. Respiratory Diseases Diagnostic Testing Report Years Considered Figure 8. Product Picture of Imaging Test Figure 9. Product Picture of Respiratory Measurement Figure 10. Product Picture of Blood Gas Test Figure 11. Product Picture of Other Figure 12. Global Respiratory Diseases Diagnostic Testing Market Share by Type in 2022 & 2028 Figure 13. Global Respiratory Diseases Diagnostic Testing Market Size by Type (2017-2028) & (US$ Million) Figure 14. Global Respiratory Diseases Diagnostic Testing Market Share by Type (2017-2028) Figure 15. United States Respiratory Diseases Diagnostic Testing Market Share by Type in 2022 & 2028 Figure 16. United States Respiratory Diseases Diagnostic Testing Market Size by Type (2017-2028) & (US$ Million) Figure 17. United States Respiratory Diseases Diagnostic Testing Market Share by Type (2017-2028) Figure 18. Product Picture of Hospitals Figure 19. Product Picture of Physician Clinics Figure 20. Product Picture of Clinical Laboratories Figure 21. Product Picture of Others Figure 22. Global Respiratory Diseases Diagnostic Testing Market Share by Application in 2022 & 2028 Figure 23. Global Respiratory Diseases Diagnostic Testing Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Respiratory Diseases Diagnostic Testing Market Share by Application (2017-2028) Figure 25. United States Respiratory Diseases Diagnostic Testing Market Share by Application in 2022 & 2028 Figure 26. United States Respiratory Diseases Diagnostic Testing Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Respiratory Diseases Diagnostic Testing Market Share by Application (2017-2028) Figure 28. North America Respiratory Diseases Diagnostic Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Respiratory Diseases Diagnostic Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Respiratory Diseases Diagnostic Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. UAE Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Philips Healthcare Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 57. BD Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 58. Abbott Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 60. Roche Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 61. ResMed Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 62. Fischer & Paykel Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 63. Medtronic Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 64. MGC Diagnostics Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Philips Healthcare BD Abbott Thermo Fisher Scientific Roche ResMed Fischer & Paykel Medtronic MGC Diagnostics